Navigation Links
Five-Year SIMPONI Data Reported In Treatment Of Signs And Symptoms Of Moderately To Severely Active Rheumatoid Arthritis
Date:6/12/2013

MADRID, June 12, 2013 /PRNewswire/ -- Janssen Biotech, Inc. announced today new five-year data from three pivotal Phase 3 studies evaluating SIMPONI® (golimumab) 50 mg administered subcutaneously once every four weeks in the treatment of moderately to severely active rheumatoid arthritis (RA).  The new findings from open-label, long-term extensions of the pivotal registration trials are results from the use of SIMPONI in several RA populations.  The populations studied included patients naive to methotrexate, patients with active disease despite methotrexate (MTX) and patients who had previously received anti-tumor necrosis factor (anti-TNF) agents.  Among patients continuing treatment with SIMPONI 50 mg in combination with methotrexate or other disease-modifying antirheumatic drugs (DMARDs) through five years, between 60 and 85 percent of patients experienced at least a 20 percent improvement in American College of Rheumatology criteria (ACR 20) at the end of the treatment period. The findings are being presented at the 2013 European League Against Rheumatism (EULAR) Annual Congress."These five-year data are important and provide rheumatologists insights into how patients living with a chronic inflammatory disease like rheumatoid arthritis may respond over time," said Josef Smolen, M.D., Professor and Chairman, Department of Rheumatology, Medical University of Vienna, Vienna, Austria and lead study investigator.  "Golimumab continues to be an important therapeutic option for patients living with moderately to severely active rheumatoid arthritis."

Five-year Safety and Efficacy of Golimumab in Methotrexate-naive Patients with Rheumatoid Arthritis: Final Study Results of the Phase 3, Randomized, Placebo-controlled GO-BEFORE Trial
An analysis using observed data from the Phase 3 GOlimumab Before Employing meth
'/>"/>

SOURCE Janssen Biotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Adverse Effects in AIM-HIGH trial of Niaspan are Consistent With the Results Reported From HPS2-THRIVE Trial of ER Niacin Plus Laropiprant
2. Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice
3. MedQIA unique CAD algorithm for Quantitation of lung involvement in diffuse lung disease used as treatment efficacy end point in study to be reported at the ERS Annual Conference in Vienna, Austria: September 1-5, 2012
4. Lilly Revises 2012 Reported Guidance to Reflect Income from Early Payment of Amylin Obligations
5. Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
6. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
7. Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
8. Research Report on Chinas High-End Medical Treatment Industry, 2013-2017
9. Despite the Numerous Agents in Development for the Treatment of Chronic HCV Infections, a Notable Share of Physicians in Europe Lack Awareness of the HCV Pipeline
10. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
11. CSL Behring Doses First Patient in Part 3 of Global Phase I/III Pivotal Study of rVIII-SingleChain (Recombinant Single-Chain Factor VIII) for Treatment of Hemophilia A
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... BCC Research report discusses the medical device technologies in terms ... and opportunities for different devices and regions. It includes forecasts ... the report focuses on technological trends in recent years in ... and Japan . Use ... device technologies market. - Analyze market structure, including segments and ...
(Date:9/18/2014)... , Sept. 18, 2014   Fruit Street Health ... an initial seed round of funding. ... led by a series of individual investors, the majority ... participated in the initial round are; Houston Cardiology ... Center Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)...  ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has ... corporate Advisory Board for business development. ... Medical School and Visiting Professor at the University ... degree in Electronics Engineering and his Ph.D. in ... After spending a year as a visiting researcher ...
Breaking Medicine Technology:Medical Devices: Technologies and Global Markets 2Medical Devices: Technologies and Global Markets 3Medical Devices: Technologies and Global Markets 4Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3
... KONG, Dec. 21, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech ... 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, today announced ... shares in December 2011, equivalent to 0.49% of the ... of HK$0.84 per share.Mr. KAM Yuen, Chairman and Chief ...
...  BioDelivery Sciences International, Inc. (Nasdaq: ... study, BNX-102, assessing the pharmacokinetics of its ...  The results confirm the final formulation and ... the pivotal comparative pharmacokinetic study versus Suboxone.  ...
Cached Medicine Technology:Golden Meditech Repurchases Shares 2BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study 2BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study 3BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study 4
(Date:9/18/2014)... Atlanta, Georgia (PRWEB) September 18, 2014 ... announced the winners of its 2nd TAG Social Savvy ... the Junior Achievement’s Chick-fil-A Foundation Discovery Center in Downtown ... social media. , Turner Sports was honored with ... This year’s event also recognized innovators in 6 ...
(Date:9/18/2014)... A sold-out crowd of more than ... supported United Way of Westchester and Putnam ... event Monday, Sept. 15. Proceeds from the event will ... and Putnam, such as providing healthy foods to low-income ... risky behaviors like drug and alcohol usage. , Two ...
(Date:9/18/2014)... News) -- Teens and young adults who,ve been mentored ... provides them with greater responsibility and independence early on ... "We found that having a mentor provides a clear ... author, Steve McDonald, an associate professor of sociology at ... release. In conducting the study, published online ...
(Date:9/18/2014)... show promise in slowing the progression of mesothelioma, ... to asbestos. Scientists from Case Western Reserve University ... application of curcumin, a derivative of the spice ... protein inhibitor known to combat the progression of ... 14 online edition Clinical Cancer Research ; ...
(Date:9/18/2014)... Research led by Paulo Rodriguez, PhD, an assistant ... Health New Orleans, Stanley S. Scott Cancer Center, has ... Chop plays in the body,s ability to fight cancer. ... the activity and accumulation of cells that suppress the ... Orleans research team showed that when they removed Chop, ...
Breaking Medicine News(10 mins):Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 2Health News:United Way Celebrates “Best Chefs and Fine Wines” at Sold-Out Culinary Event 3Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 2Health News:Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize STAT3 in mesothelioma 3Health News:LSU Health research discovers means to free immune system to destroy cancer 2
... of heart disease. But almost everyone feels that exercising is ... that skinny people are also prone to developing heart diseases ... genesis of various heart ailments. ,Dr. Peter T. Katzmarzyk ... study, says that heart disease does not develop from a ...
... is playing havoc with the economies of,developed countries like ... of vaccinating the animals for the past three decades. ... regular basis is the best,means of preventing the spread ... joint,director of the Bangalore-based Indian Veterinary Research Institute (under,ICAR), ...
... government says that smoking will turn out to be the ... of even HIV. The British broadcasting corporation reported on Monday ... than any other disease in the next 20 years. The ... United Kingdom, says smoking and other tobacco related deaths would ...
... has zeroed in on the culprit behind the falling age ... said to be the cause for girls attaining puberty as ... explanation for this is growing childhood obesity, intake of rich ... the role of estrogen, a female hormone, in attaining puberty.,They ...
... Most people are paranoid about heart disease. One survey said ... hepatitis and heart disease. Whenever people get to read something ... they start worrying at times over trivial problems based on ... recent study conducted in Austria says that chronic infections can ...
... an associate professor of computer science at the Washington ... the way children understand and speak languages at such ... meeting of the American association for the advancement of ... to pick up language and to become familiar with ...
Cached Medicine News:Health News:India takes on foot-and-mouth disease by vaccinating animals 2
For the qualitative detection of human Chorionic Gonadotrophin (HCG) in urine or urine and serum specimens...
ZyDoc offers a full medical transcription and documentation solution....
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: